Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
AFRICA – Africa Reproductive Care society (ARCS) has championed for fertility care and women’s healthcare capacity building in partnership with Merck Foundation. The Merck Foundation, the philanthropic arm of Merck…
Read More
USA – According to a news release from, Merck, the Food and Drug Administration (FDA) has approved Keytruda (pembrolizumab) for the treatment of patients with advanced endometrial carcinoma that is…
Read More
USA – Merck has released specific data for Keytruda in early-stage lung cancer, indicating an advantage over Roche’s first-to-market Tecentriq. Postsurgery use of Keytruda reduced the risk of disease recurrence…
Read More
USA – Merck & Co. has halted a Phase 3 trial testing a combination of two widely used cancer drugs, Keytruda and Lynparza, in patients with advanced prostate tumors due…
Read More
USA –The Digital Medicine Society (DiMe) has announced a new collaboration involving Biogen, Eisai, Eli Lilly, and Merck & Co. to address a major barrier in determining whether potential treatments…
Read More
USA – The FDA has expanded Lynparza (olaparib) approval by AstraZeneca and Merck & Co. to include adjuvant treatment of germline BRCA-mutated (gBRCAm) HER2-negative, high-risk, early breast cancer in patients…
Read More
USA – Merck Animal Health has received FDA approval for NUFLOR-S (florfenicol) Injectable Solution and AROVYN (tulathromycin injection) – broad-spectrum, prescription antibiotics that treat the most important organisms associated with…
Read More
SWITZERLAND –The World Health Organization has conditionally recommended the antiviral drug molnupiravir for patients with non-severe COVID-19 infection who are at high risk of hospitalization. The WHO Guideline Development Group…
Read More
AFRICA – Merck Foundation, the philanthropic arm of Merck KGaA Germany, champions for girls’ empowerment and education to eliminate Female Genital Mutilation (FGM) from African communities. The foundation aims to…
Read More
SWITZERLAND – Two private equity giants are discussing launching a joint bid for Novartis’ generics unit, Bloomberg has reported. Novartis announced last year that it was conducting a strategic review…
Read More